key: cord-0870439-wfp5cqgp authors: Chamseddine, A.; Soudani, N.; Kanafani, Z.; Alameddine, I.; Dbaibo, G.; Zaraket, H.; El-Fadel, M. title: Detection of influenza virus in air samples of patient rooms date: 2020-11-02 journal: J Hosp Infect DOI: 10.1016/j.jhin.2020.10.020 sha: 16e598c534d904a8c0b8a9be9ddd38d69fa8df1e doc_id: 870439 cord_uid: wfp5cqgp BACKGROUND: Understanding the transmission and dispersal of influenza and respiratory syncytial virus (RSV) via aerosols is essential for the development of preventative measures in hospital environments and healthcare facilities. METHODS: During the 2017-2018 influenza season, patients with confirmed influenza or RSV infections were enrolled. Room air samples were collected close to (0.30 m) and far (2.20 m) from the patient’s head. Real-time polymerase chain reaction (PCR) was used to detect and quantify viral particles in the air samples. Plaque assay was used to determine the infectiousness of the detected viruses. FINDINGS: Fifty-one air samples were collected from the rooms of 29 patients with laboratory-confirmed influenza; 51% of the samples tested positive for influenza A virus (IAV). Among IAV-positive patients, 65% were emitters (have at least one positive air sample) reflecting a higher risk of nosocomial transmission compared to non-emitters. The majority (61.5%) of the IAV-positive air samples were collected at 0.3 m distance from the patients’ head, while the remaining were collected at 2.2 m. The positivity rate of IAV in air samplers was influenced by the distance from the patient’s head and the day of collection post-hospital admission. Only three patients with RSV infection were recruited and none were emitters. CONCLUSION: This study demonstrates that influenza can be aerosolized beyond one meter in patient rooms, a distance considered to be safe by infection control practices. Further investigations are needed to determine the extent of infectivity of the aerosolized virus particles. Monitoring and controlling microbiological contaminants, including respiratory viruses in hospitals' indoor air, have become an integral part of infection prevention strategies in hospitals [1, 2] . In recent years, the debate and concerns regarding the potential of airborne transmission of respiratory viruses have intensified with the emergence of the avian influenza virus, SARS-CoV1, and MERS-CoV [3] [4] [5] . More recently, the concerns over airborne infections have resurfaced with the COVID-19 pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV2). It was reported that bioaerosols carrying SARS-CoV2 could remain suspended in the air for a few hours [6] . Several groups have also detected SARS-CoV2 RNA in air samples collected in hospital rooms, supporting the potential transmission of SARS-CoV2 via aerosols in indoor environments [7] . The World Health Organization (WHO) highlighted the risk of airborne transmission during procedures that generate bioaerosols such as intubation, tracheostomy, open suction, and manual ventilation [8] . The COVID-19 pandemic raised many questions regarding how much we know about airborne infections. Influenza and respiratory syncytial virus (RSV) are the main causes of respiratory infections that require hospitalization. Most of the severe and life-threatening complications associated with influenza and RSV infections are observed in infants, elderly, and immunocompromised [9, 10] . Influenza is a highly contagious respiratory virus estimated to infect annually aound 5 -10% of adults and 20 -30% of children resulting in up to 650 000 deaths globally [11, 12] . Influenza A virus (IAV) has numerous subtypes and a broad host range; they are of particular concern as they have historically caused several pandemics [13, 14] . Annual influenza outbreaks are mainly caused by IAV (H1N1 and H3N2 subtypes) and B viruses [14, 15] . RSV, on the other hand, is a major cause of moderate to severe respiratory infections [16] [17] [18] . In 2015, it was estimated that 33.1 million episodes of RSV resulted in about 3.2 million hospitalizations and around 60 000 in-hospital deaths among children younger than 5 years [17] . Vulnerable patients infected with RSV are likely to experience extended hospital stays with increased risk of morbidity and mortality [18] [19] [20] . Both the influenza virus and RSV spread indirectly through contact with contaminated surfaces or via respiratory droplets and aerosols particularly in crowded areas [12, [21] [22] [23] [24] [25] [26] . These particles cause infections in people in close vicinity, as they settle in the upper respiratory tract. Airborne transmission occurs via J o u r n a l P r e -p r o o f droplet nuclei < 5 µm, which remain suspended in the air and can be disseminated to long distances by the air current. Although these aerosolized particles contain a low concentration of infectious particles, they are likely to cause lower respiratory tract infections because of their fine size [3, 27, 28] . Several international organizations such as the Institute of Medicine, the European Center for Disease and Control, the Center for Disease Control and Prevention (CDC) and the World Health Organization (WHO) highlight the need for further research regarding influenza virus and other respiratory viruses transmission routes [11, 12, 14, [29] [30] [31] [32] [33] . Nosocomial transmission of influenza or RSV has been well documented and constitutes a major concern for hospitalized patients given their vulnerability to developing severe diseases [21, 30, [34] [35] [36] [37] [38] . The rate of healthcare-associated influenza infections ranges between 2-7% [39] [40] [41] . Data from the United States revealed that the median duration of hospital stay was significantly longer for nosocomial influenza cases compared to community-acquired cases (7.5 vs 3 days, respectively) [41] . Nosocomial infections were also associated with poor clinical outcomes including ICU admission and deaths. Therefore, it is essential to follow and enhance infection control guidelines to minimize the occurrence of these infections in health care settings. Health care providers are requested to adhere to droplet precautions when dealing with patients infected with influenza or RSV [29, 42] . Droplet precautions include wearing a surgical mask, maintaining a one-meter distance with the patient, and placing patients in a single room if possible or physically separated (> 1 m between beds) [43] . Also, the patient should use a mask, follow cough and sneezing etiquette, and hand hygiene. However, these guidelines remain controversial, with more evidence to support aerosols' role in influenza and RSV transmission. In this study, we assessed the presence of airborne influenza virus and RSV in patient's rooms. ethanol to prevent potential carry-over contamination. Temperature and relative humidity were also monitored and recorded inside the patients' rooms using VELOCICALC ® Air Velocity Meter Model 9545 (TSI Corporation 500 Cardigan Road Shoreview, USA). The samples were immediately transported on ice to the laboratory, where they were aliquot and stored at -80 o C. Within one week of sample collection, RNA was extracted from a one mL sample aliquot using PureLink Viral RNA/DNA Mini Kit (Invitrogen) according to the manufacturer's specifications. The specimens were screened for influenza A/ B viruses and RSV by real-time PCR (RT-PCR) using primers and probes specific for the M gene, NS gene, and G gene, respectively [44] [45] [46] [47] . The sequences of primers and probes were obtained from the Center for Disease Control and Prevention (CDC, USA), and the experimental procedure was done as previously described [47] . In brief, One-Step RT-PCR AgPath-ID™ J o u r n a l P r e -p r o o f (Thermo Fisher Scientific) was used to amplify the target sequences on a CFX96 real-time PCR system-Bio-Rad. Influenza A and B were multiplexed, whereas RSV was screened independently according to the following protocol: 45°C for 10 min, 95°C for 10 min, then 45 cycles of 95°C for 15 sec, and 55°C for 1 min. All the runs were performed in the presence of a no-template control (NTC) and positive control for each target. Extraction controls were screened to exclude cross-contamination during extraction. Influenza Apositive samples were further subtyped via RT-PCR. The viral copy number of influenza (M gene) in each sample was quantified relative to a standard curve obtained from a serial dilution of a known concentration of purified complete genome containing the gene of interest (MBC028 from Vircell). The cycle threshold (C t ) obtained by RT-PCR from each sample was plotted to determine the equivalent M gene copy number (copies /m 3 ) according to the following formula: Where the M gene copy number was calculated relative to the standard curve (copies/µl). V extract represents the eluted volume from the extraction (µl), V PCR is the volume analyzed by RT-PCR (µl), U is the airflow rate (m 3 /minute), and t is the sampling duration (minutes). The detection and quantification of the infectious virus in the air samples was performed using plaque assay as previously described [47] . Briefly, at the end of the influenza season, an aliquot of each sample was thawed and serially diluted (10 -folds). MDCK cells seeded in six well-plates were inoculated with 200 µl of each dilution and incubated at 37°C for 1 h with shaking every 15 minutes. Then, the cells were covered with 3 ml of 0.5% nutritive overlay. After 72 h, the cells were stained with crystal violet solution. Statistical analysis was performed using Prism 7 software. Pearson Chi-square analysis with 95% confidence intervals (CI) (p < 0.05) was used to assess the association between virus shedding and various factors such as age-group and distance. The Welch's unequal variances t-test was used to assess the relationship between the viral copy number relative to the days J o u r n a l P r e -p r o o f elapsed since hospital admission and to determine the influence of coughing and sneezing on IAV emission. For continuous variables, means and SDs were calculated, and statistical significance was indicated upon obtaining (p < 0.05). This study was approved by the Institutional Review Board (IRB) at the American University of Beirut (AUB) and the hospital's administration. All patients provided written informed consent before sample collection. The sampling procedures performed did not replace or obstruct routine medical care procedures and institutional protocols of the hospital. J o u r n a l P r e -p r o o f A total of twenty-nine subjects (11 males and 18 females) with confirmed IAV virus (n = 26) or RSV (n = 3) infections were recruited. All IAV patients were administered antiviral treatment upon hospitalization. Seventeen out of 26 IAV patients were considered "emitters", defined as having at least one positive air sample ( Table I) . The rate of detection did not differ significantly among the different age groups in this study (p-value > 0.05) ( Table I) . Details on the collected air samples are presented in Appendix A. Our results showed that 51% ( contact with fomites [48] . The COVID-19 pandemic revived the debate regarding the potential of airborne transmission for respiratory viruses and highlighted the gaps in our knowledge regarding this transmission route and its consequences on infection control guidelines [49, 50] . In this study, we investigated the aerosolization of influenza and RSV in the rooms of patients to assess the appropriateness of the recommended infection control procedures. We detected influenza viral RNA in 51% of the air samples collected from the rooms of influenza-infected patients. These patients were classified as emitters with a relatively higher risk for nosocomial transmission via the airborne route than non-emitters. Our results support previous findings indicating that sneezing and coughing are significantly associated with higher detection of the influenza virus in the air samples [30] . However, sneezing or coughing alone were not associated with higher levels of influenza emission compared to the asymptomatic group. This is consistent with previous studies showing that simple breathing (exhalation) is enough for aerosolization of the virus [51] . Also, mouth breathing was found to exceed nose breathing, talking, and coughing in the generation of very fine aerosols (1 µm) [52] . However, contrary to previous studies, we were not able to demonstrate that the aerosolized virus retained its infectivity [49] [50] [51] . This might be attributed to the harsh conditions generated inside the air sampling machine [53] or the sensitivity of the plaque assay method, which has a detection limit of 500 pfu/ml [54] . Current, guidelines for epidemic-and pandemic-prone acute respiratory infections including those for COVID-19 recommend airborne precautions when aerosol generating procedures such as intubation and ventilation are being performed [55] [56] [57] . However, studies including ours demonstrate that even in absence of such procedures the virus could be detected in the air of patients' rooms suggestive of aerosolization, warranting reconsideration of existing guidelines [7, 32, 34, 51, 58] . Influenza virus transmission is reported primarily by large droplets traveling up to 1 m from the source [14, 29, 59] . Consistently, in this study, we found that the majority of air samples Kulkarni et al. [60] previously showed that RSV-infected children hospitalized for bronchiolitis produce aerosols that contain infectious virus particles. While Wan et al. [61] reported that RSV was detected in only 1 out of 13 samples collected at a close distance (0.6-1.8m) and none found in far distance air samples. In this study, none of the air samples that were collected from the rooms of three RSV-infected patients were positive by RT-PCR. The lack of RSV detection in the air samples might be attributed to the small number of RSVpatients included in this study. Furthermore, the respiratory symptoms in RSV-infected patients usually appear around 3 days prior to hospital admission [62, 63] . Therefore, the lack of sampling on day one of admission from RSV-patients' room might have also reduced our ability to detect the virus in the air. Moreover, the shorter duration (10 mins) of air sampling in our study compared to 30 mins in the study by Kulkarni et al [60] might have influenced RSV detection in the collected air samples. Another factor could be the degradation of the RSV virus during sampling and/or the differences in sampling efficiencies of various air samplers [53] . Adults shed influenza virus for an average of one week with a peak on the second day of the illness, whereas shedding cessation in children can be prolonged with a noticeable decline in RNA detection in the samples collected in the subsequent days [27, 64, 65] . A study in Germany showed that the mean duration of symptoms before admission to the emergency department was 5.2 days and did not differ significantly between influenza A and B [66] . Similarly, a study in China estimated the duration from onset of symptoms to hospitalization for IAV patients to be 5.9 days; although it was longer than that for influenza B patients (3.7 days). In our study, a higher influenza viral load was detected in the samples that were collected on the first day after hospital admission compared to the samples that were collected on the second and third days. Therefore, it is likely that these patients were already clearing the virus particularly that they were on antiviral therapy. These findings are consistent with previous studies showing that the highest influenza viral load is detected on day 0 of hospitalization in oseltamivir treated patients [67, 68] . Our findings are also in line J o u r n a l P r e -p r o o f with studies done in college communities and multicentre areas, which revealed a negative association between the detection of aerosolized IAV and the time elapsed since illness onset [51, 58] . Our study also supports previous findings that not all patients similarly emit influenza viruses [30, 32, 33, 69] . Hence, the identification of super emitters and factors associated with this may improve our understanding of influenza virus transmission. The study's limitations include the sample size and the lack of clinical data (e.g., vaccination history, body mass index, etc.) which precludes the analysis of more complex variables that might affect the presence of airborne viruses. Also, our samples were collected from the rooms of symptomatic patient rooms only and in departments that were accessible for this type of work. Thus, we did not address the risk of asymptomatic virus emitter, nor were we able to access the emergency department, which might be a hub for the dissemination of respiratory viruses. Regardless of these limitations, our study offers valuable information for infection prevention and control practices in hospitals and questions the notion of safe distance of one-meter. J o u r n a l P r e -p r o o f 1 . Dimensions and sampling locations of patient room (Coriolis µ Biological Air Sampler was placed at 1.5m above ground i.e. breathing zone level). Two samples (whenever tolerated by the patient) were collected from patient rooms, samples that were close to the patient (~ 0.3m) were labeled as "A" while those collected far from patients (~ 2.2m) were labeled as "B". J o u r n a l P r e -p r o o f Indoor air quality in two French hospitals: Measurement of chemical and microbiological contaminants The spread of influenza and other respiratory viruses: complexities and conjectures Inhaling to mitigate exhaled bioaerosols East respiratory syndrome coronavirus (MERS-CoV) -The Kingdom of Saudi Arabia COVID 19 can spread through breathing, talking, study estimates How can airborne transmission of COVID-19 indoors be minimised? Modes of transmission of virus causing COVID-19: implications for IPC precaution recommendations n Influenza-and RSV-associated hospitalizations among adults Influenza-and respiratory syncytial virus-associated mortality and hospitalisations WHO | Infection prevention and control of epidemic-and pandemic prone acute respiratory infections in health care Excess of Mortality in Adults and Elderly and Circulation of Subtypes of Influenza Virus in Southern Brazil Disease Burden of Influenza | CDC CDC 2009 H1N1 Flu n.d Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study Respiratory Syncytial Virus Infection in Elderly and High-Risk Adults High morbidity and mortality in adults hospitalized for respiratory syncytial virus infections Respiratory syncytial virus infection-associated hospitalization in adults: a retrospective cohort study Characteristics of patients with hospital-acquired influenza A (H1N1)pdm09 virus admitted to the intensive care unit Influenza vaccination in preventing outbreaks in schools: A long-term ecological overview The effectiveness of influenza vaccination among nursery school children in China during the 2016/17 influenza season Respiratory syncytial virus infection in elderly adults Development of respiratory syncytial virus (RSV) vaccines for infants Respiratory syncytial virus burden among adults during flu season: an underestimated pathology Transmission of influenza: implications for control in health care settings Influenza Virus in Human Exhaled Breath: An Observational Study Prevention Strategies for Seasonal Influenza in Healthcare Settings | CDC 2018 Exposure to influenza virus aerosols during routine patient care The spread of influenza and other respiratory viruses: complexities and conjectures Review of aerosol transmission of influenza A virus Influenza A virus transmission: contributing factors and clinical implications Measurement of airborne influenza virus in a hospital emergency department Molecular characteristics of outbreaks of nosocomial infection with influenza A/H3N2 virus variants Viral influenza-like illnesses: dynamic interrelationships during the 2015-2016 influenza season in hospitalized patients Quantification of Influenza Virus RNA in Aerosols in Patient Rooms Nosocomial RSV infection control and outbreak management Nosocomial Pandemic (H1N1) Laboratoryconfirmed pandemic h1n1 influenza in hospitalized adults: findings from the Canadian Nosocomial Infections Surveillance Program Hospitalonset influenza hospitalizations--United States Bennett & Brachman's Hospital Infections Isolation Precautions | Guidelines Library | Infection Control | CDC 2020 WHO | CDC protocol of realtime RTPCR for influenza A (H1N1). WHO n Influenza surveillance from Viral Respiratory Infections in Preterm Infants during and after Hospitalization Ceramide Suppresses Influenza A Virus Replication In Vitro Significance of Fomites in the Spread of Respiratory and Enteric Viral Disease Particle sizes of infectious aerosols: implications for infection control It is Time to Address Airborne Transmission of COVID-19 Infectious virus in exhaled breath of symptomatic seasonal influenza cases from a college community The Size Distribution of Droplets in the Exhaled Breath of Healthy Human Subjects Comparative Testing and Evaluation of Nine Different Air Samplers: End-to-End Sampling Efficiencies as Specific Performance Measurements for Bioaerosol Applications Propagation and Characterization of Influenza Virus Stocks That Lack High Levels of Defective Viral Genomes and Hemagglutinin Mutations Rational use of personal protective equipment for coronavirus disease (COVID-19) and considerations during severe shortages n WHO | Infection prevention and control of epidemic-and pandemic prone acute respiratory infections in health care Cent Dis Control Prev 2020 The environmental deposition of influenza virus from patients infected with influenza A(H1N1)pdm09: Implications for infection prevention and control General Information n Evidence of Respiratory Syncytial Virus Spread by Aerosol. Time to Revisit Infection Control Strategies? Detection of Common Respiratory Viruses and Mycoplasma pneumoniae in Patient-Occupied Rooms in Pediatric Wards Predictors and incidence of hospitalization due to respiratory syncytial virus (RSV)-associated lower respiratory tract infection (LRTI) in non-prophylaxed moderate-to-late preterm infants in Bosnia and Herzegovina Predictors of Severity and Mortality in Children Hospitalized With Respiratory Syncytial Virus Infection in a Tropical Region Viral shedding and clinical illness in naturally acquired influenza virus infections The Timeline of Influenza Virus Shedding in Children and Adults in a Household Transmission Study of Influenza in Managua Clinical Characteristics of Influenza in Season Influenza A(H1N1)pdm09 infection and viral load analysis in patients with different clinical presentations Prolonged viral shedding in pandemic influenza A(H1N1): clinical significance and viral load analysis in hospitalized patients Transmissibility and severity of influenza virus by subtype The authors would like to thank the hospitals' administration, Dr. Yolla Youssef, and nurse managers for facilitating the sampling program. None This study is supported through joint funding from the Lebanese National Council for Scientific Research (LNCSR) and the American University of Beirut (AUB). Additional funding for equipment was obtained through the Dar Al-Handasah (Shair & partners) endowed chair fund.Appendix A. Summary of air quality data collected from patient rooms. a Two samples were collected from patient rooms, samples that were close to the patient (~ 0.3m) were labeled as "A" while those collected far from patients (~ 2.2m) were labeled as "B". b Age (m = months; y = years). c Sex (M = male; F = Female). d ND = Not determined. e Emitters were defined as patients whose air sample is positive for influenza by RT-PCR. f Only three RSV patients were recruited in this study and their air samples were collected on admission days 2, 3, and 1 respectively, but none has yielded positive results. g All influenza patients were on anti-viral medication treatment and no visitors, relatives or healthcare workers were inside patient rooms during sampling.